Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan versus omeprazole in high-dose amoxicillin dual therapy for Helicobacter pylori eradication
PACTR202510527035890Phase 4Completed
- Sponsor
- Al-Azhar University
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of vonoprazan, omeprazole and amoxicillin in Helicobacter pylori infection (2 arms), sponsored by Al-Azhar University. Primary endpoint: Helicobacter pylori eradication rate. Started Jul 2024; status: completed.
02
Drugs
vonoprazanomeprazoleamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on PACTR202510527035890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202510527035890.